top of page

Expanding Cures

Biology-first Manufacturing

for Scalable Cell Therapy

3_DevicesTogether-3-square.jpg
Platform_Harton.jpg
Gradient1_Harton.jpg

OUR VISION

The future of cell production,
beyond the speed of disease,
scaled to treat every patient 

The GMP-Ready
Platform for Advanced
Cell Manufacturing

Manufacture Human Biology. In 3D. At Scale.

Built for
Today's Therapies and Tomorrow's Breakthroughs

Partner with Us

3_DevicesTogether-1v2 NoTubes_edited_edited.jpg

The GMP-Ready Platform 
for Advanced Cell Manufacturing

3_DevicesTogether-1 NoTubes.jpg

The GMP-Ready Platform
for Advanced Cell Manufacturing

Built for Performance
Across Every Workflow

HT-1 delivers biology-first manufacturing in a closed, GMP-ready platform—combining perfused 3D culture, integrated unit operations, and automated control to deliver high-fidelity human cells from research and development through commercial manufacturing. 

Intuitive Operation

Streamlined ready-run-release workflow

Intelligent Automation

End-to-end digital process control 

Full-Stack Integration

One single-use consumable

Lower Cost per Dose

More cells, less labor

Manufacture Human Biology.
In 3D. At Scale.

3D Culture for
True Human Biology

Harton’s Solid-State Bioprocessor creates a structured, perfused microenvironment that preserves phenotype and function while enabling high-density growth. 

Biological Fidelity

Tissue-like structure allows cells to express their natural phenotypes and functions.

High-Viability Growth

Perfusion reproduces in vivo fluidic forces to sustain cellular metabolism and health.

Programmable Control

Tunable 3D matrix composition, mechanics, and biochemical cues precisely shape cell state.

Scalable Production

Multi-billion-cell yields in a compact cartridge support clinical and commercial manufacturing.

_HT-1 Lab_edited.jpg

Built for Today's Therapies
and Tomorrow's Breakthroughs

Supported Applications

Harton's biology-first platform supports diverse human cell types and therapeutic modalities—from immune cell therapies to engineered and stem-derived cells—enabling reproducible manufacturing across research and clinical products.

Immune Cell Therapies

T cells and engineered immune programs across autologous and allogeneic workflows.

HSPCs & Progenitors

Early-lineage and hematopoietic cell expansion where stem-like potential must be preserved.

Precision Engineered Cells

Viral and non-viral modification workflows with integrated editing, recovery, and expansion.

Stem-Derived Cells & Engineered Tissues

Differentiation, maturation, and co-culture programs where structure determines function.

Partner with Us_Harton_edited.jpg

Discover how Harton enables researchers, biotech and pharma teams, and manufacturing partners to produce high-quality human cells at scale and accelerate the next generation of cell-based medicines. 

SPEAK TO AN EXPERT
_HT-1 Lab.jpg
Partner with Us_Harton_edited.jpg

Partner with Us

Discover how Harton enables researchers, biotech and pharma teams, and manufacturing partners to produce high-quality human cells at scale and accelerate the next generation of cell-based medicines.

bottom of page